Xylem (NYSE:XYL - Get Free Report) had its price target reduced by analysts at Stifel Nicolaus from $166.00 to $150.00 in a report released on Friday,Benzinga reports. The firm presently has a "buy" rating on the industrial products company's stock. Stifel Nicolaus' target price would suggest a potential upside of 23.42% from the stock's current price.
Several other research firms have also issued reports on XYL. TD Cowen reduced their target price on Xylem from $138.00 to $125.00 and set a "hold" rating on the stock in a report on Wednesday, November 6th. Wolfe Research reiterated a "peer perform" rating on shares of Xylem in a report on Thursday, December 12th. Robert W. Baird reduced their price objective on Xylem from $175.00 to $154.00 and set an "outperform" rating for the company in a research note on Friday, November 1st. Citigroup cut their target price on Xylem from $148.00 to $147.00 and set a "buy" rating on the stock in a research report on Monday, January 13th. Finally, Royal Bank of Canada dropped their price target on Xylem from $163.00 to $162.00 and set an "outperform" rating on the stock in a report on Friday, November 1st. Three research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. Based on data from MarketBeat, Xylem presently has a consensus rating of "Moderate Buy" and a consensus target price of $150.50.
Read Our Latest Research Report on XYL
Xylem Stock Performance
NYSE XYL traded down $0.05 on Friday, reaching $121.53. The stock had a trading volume of 1,066,223 shares, compared to its average volume of 953,177. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.96 and a quick ratio of 1.42. The firm has a fifty day moving average of $120.88 and a two-hundred day moving average of $128.41. Xylem has a 1-year low of $111.72 and a 1-year high of $146.08. The company has a market cap of $29.53 billion, a P/E ratio of 35.54, a price-to-earnings-growth ratio of 2.05 and a beta of 1.06.
Xylem (NYSE:XYL - Get Free Report) last issued its quarterly earnings data on Thursday, October 31st. The industrial products company reported $1.11 EPS for the quarter, meeting analysts' consensus estimates of $1.11. Xylem had a return on equity of 9.61% and a net margin of 9.85%. The firm had revenue of $2.10 billion for the quarter, compared to analyst estimates of $2.17 billion. During the same period in the prior year, the firm posted $0.99 EPS. The company's revenue for the quarter was up .2% on a year-over-year basis. On average, equities research analysts anticipate that Xylem will post 4.23 EPS for the current year.
Institutional Trading of Xylem
A number of hedge funds and other institutional investors have recently made changes to their positions in XYL. Thrivent Financial for Lutherans grew its position in Xylem by 399.2% during the second quarter. Thrivent Financial for Lutherans now owns 51,282 shares of the industrial products company's stock worth $6,955,000 after buying an additional 41,010 shares in the last quarter. Public Sector Pension Investment Board grew its position in Xylem by 77.3% during the second quarter. Public Sector Pension Investment Board now owns 9,410 shares of the industrial products company's stock worth $1,276,000 after buying an additional 4,103 shares in the last quarter. Marshall Wace LLP grew its position in Xylem by 433.0% during the second quarter. Marshall Wace LLP now owns 229,082 shares of the industrial products company's stock worth $31,070,000 after buying an additional 186,105 shares in the last quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp grew its position in Xylem by 60.9% during the second quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 46,302 shares of the industrial products company's stock worth $6,280,000 after buying an additional 17,519 shares in the last quarter. Finally, Point72 Asia Singapore Pte. Ltd. grew its position in Xylem by 349.5% during the second quarter. Point72 Asia Singapore Pte. Ltd. now owns 2,135 shares of the industrial products company's stock worth $290,000 after buying an additional 1,660 shares in the last quarter. 87.96% of the stock is currently owned by institutional investors.
About Xylem
(
Get Free Report)
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
See Also
Before you consider Xylem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.
While Xylem currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
